Access Biotechnology is the biotechnology investment arm of Access Industries, investing from New York in private and public biopharma companies across therapeutic areas, modalities and development stages. It backs biotechnology, life sciences and pharmaceutical companies in the United States and Europe, with early- and later-stage venture activity including Series A through Series C. The firm has led, co-led and participated in financings for companies developing therapies for high unmet medical needs.